相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020
Katsutoshi Tokushige et al.
JOURNAL OF GASTROENTEROLOGY (2021)
Xanthine oxidoreductase activity correlates with vascular endothelial dysfunction in patients with type 1 diabetes
Kahori Washio et al.
ACTA DIABETOLOGICA (2020)
Xanthine oxidase inhibition attenuates insulin resistance and diet-induced steatohepatitis in mice
Tomoki Nishikawa et al.
SCIENTIFIC REPORTS (2020)
Hyperuricemia precedes non-alcoholic fatty liver disease with abdominal obesity moderating this unidirectional relationship: Three longitudinal analyses
Zhimin Ma et al.
ATHEROSCLEROSIS (2020)
New insights into purine metabolism in metabolic diseases: role of xanthine oxidoreductase activity
Masato Furuhashi
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2020)
Hepatocyte-Specific Ablation or Whole-Body Inhibition of Xanthine Oxidoreductase in Mice Corrects Obesity-Induced Systemic Hyperuricemia Without Improving Metabolic Abnormalities
Daniel B. Harmon et al.
DIABETES (2019)
The Liver as an Endocrine Organ-Linking NAFLD and Insulin Resistance
Matthew J. Watt et al.
ENDOCRINE REVIEWS (2019)
The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis
Zobair M. Younossi et al.
JOURNAL OF HEPATOLOGY (2019)
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
Naga Chalasani et al.
HEPATOLOGY (2018)
The role of xanthine oxidoreductase and uric acid in metabolic syndrome
Maria Giulia Battelli et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2018)
Japanese Clinical Practice Guideline for Diabetes 2016
Masakazu Haneda et al.
JOURNAL OF DIABETES INVESTIGATION (2018)
Xanthine oxidoreductase activity is correlated with insulin resistance and subclinical inflammation in young humans
Kahori (Watanabe) Washio et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2017)
Non-alcoholic fatty liver disease: A sign of systemic disease
Isabella Reccia et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2017)
Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis
Anna M. Diehl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Serum Macro TSH Level is Associated with Sleep Quality in Patients with Cardiovascular Risks-HSCAA Study
Manabu Kadoya et al.
SCIENTIFIC REPORTS (2017)
Hyperuricemia and risk of nonalcoholic fatty liver disease: a systematic review and meta-analysis
Shulan Gong et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2016)
Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes
Zobair M. Younossi et al.
HEPATOLOGY (2016)
Xanthine oxidoreductase activity assay in tissues using stable isotope-labeled substrate and liquid chromatography high-resolution mass spectrometry
Takayo Murase et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2016)
A highly sensitive assay of human plasma xanthine oxidoreductase activity using stable isotope-labeled xanthine and LC/TQMS
Takayo Murase et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2016)
A highly sensitive assay for xanthine oxidoreductase activity using a combination of [13C2,15N2]xanthine and liquid chromatography/triple quadrupole mass spectrometry
Takayo Murase et al.
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS (2016)
The xanthine oxidase inhibitor febuxostat suppresses development of nonalcoholic steatohepatitis in a rodent model
Yusuke Nakatsu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2015)
Serum Uric Acid Levels and Risk of Metabolic Syndrome: A Dose-Response Meta-Analysis of Prospective Studies
Huiping Yuan et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Xanthine oxidase in non-alcoholic fatty liver disease and hyperuricemia: One stone hits two birds
Chengfu Xu et al.
JOURNAL OF HEPATOLOGY (2015)
Non-invasive assessment of liver steatosis in non-alcoholic fatty liver disease
Hiromi Kan et al.
HEPATOLOGY RESEARCH (2014)
Plasma Brain-Derived Neurotrophic Factor and Reverse Dipping Pattern of Nocturnal Blood Pressure in Patients with Cardiovascular Risk Factors
Manabu Kadoya et al.
PLOS ONE (2014)
Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population
Yoshio Sumida et al.
BMC GASTROENTEROLOGY (2012)
Uric Acid Induces Hepatic Steatosis by Generation of Mitochondrial Oxidative Stress POTENTIAL ROLE IN FRUCTOSE-DEPENDENT AND -INDEPENDENT FATTY LIVER
Miguel A. Lanaspa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study
Yuichiro Eguchi et al.
JOURNAL OF GASTROENTEROLOGY (2012)
Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity
Giovanni Musso et al.
ANNALS OF MEDICINE (2011)
Hepatic steatosis index: A simple screening tool reflecting nonalcoholic fatty liver disease
Jeong-Hoon Lee et al.
DIGESTIVE AND LIVER DISEASE (2010)
Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease
Stuart McPherson et al.
GUT (2010)
Comparison of Noninvasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
Amy G. Shah et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)
Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress
Yuri Y. Sautin et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2007)
The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD
Paul Angulo et al.
HEPATOLOGY (2007)
Xanthine oxidoreductase is a regulator of adipogenesis and PPARγ activity
Kevin J. Cheung et al.
CELL METABOLISM (2007)
High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid
Jacob George et al.
CIRCULATION (2006)
Long-term follow-up of patients with NAFLD and elevated liver enzymes
Mattias Ekstedt et al.
HEPATOLOGY (2006)
Macrovesicular hepatic steatosis in living liver donors: Use of CT for quantitative and qualitative assessment
SH Park et al.
RADIOLOGY (2006)
Glycaemic control in relation to xanthine oxidase and antioxidant indices in Malaysian Type 2 diabetes patients
UR Kuppusamy et al.
DIABETIC MEDICINE (2005)
The natural history of nonalcoholic fatty liver disease: A population-based cohort study
LA Adams et al.
GASTROENTEROLOGY (2005)
Xanthine oxicloreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications
CE Berry et al.
JOURNAL OF PHYSIOLOGY-LONDON (2004)
Noninvasive evaluation of graft steatosis in living donor liver transplantation
M Iwasaki et al.
TRANSPLANTATION (2004)
The utility of radiological imaging in nonalcoholic fatty liver disease
S Saadeh et al.
GASTROENTEROLOGY (2002)
The physiology of endothelial xanthine oxidase: From urate catabolism to reperfusion injury to inflammatory signal transduction
A Meneshian et al.
MICROCIRCULATION (2002)
分享论文
